Form 4 for INTT INTEST CORP
Accepted 2026-03-18 00:00:00 ET · period of report 2026-03-16 · accession 0000891839-26-000095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-03-18 | 2026-03-16 | INTT | Grant Richard N. Jr. | Pres, CEO, Dir | A - Grant | $0.00 | +27.6K | 214.4K | +15% | $0 |
| D | 2026-03-18 | 2026-03-18 | INTT | Grant Richard N. Jr. | Pres, CEO, Dir | S - Sale | $14.28 | -1,636 | 212.7K | -0.8% | -$23.4K |
| D | 2026-03-18 | 2026-03-16 | INTT | Grant Richard N. Jr. | Pres, CEO, Dir | A - Grant | $0.00 | +23.4K | 23.4K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-16 | A | A | 13,822 | $0.00 | 200,544 | D | — | — | (F1) These restricted shares were granted pursuant to the InTest Corporation 2023 Stock Incentive Plan (the "Plan") in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 16, 2027. |
| 2 | Common | Common Stock | 2026-03-18 | S | D | 1,636 | $14.28 | 212,730 | D | — | — | (F4) The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.25 to $14.425, inclusive. The reporting person undertakes to provide InTest Corporation, any security holder of InTest Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 3 | Common | Common Stock | 2026-03-16 | A | A | 13,822 | $0.00 | 214,366 | D | — | — | (F2) These performance-based restricted shares were granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in March 2029 dependent upon certain performance criteria. The amount shown reflects the number of shares that will vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 20,733. |
| 4 | Derivative | Employee Stock Option (right to buy) | 2026-03-16 | A | A | 23,365 | $0.00 | 23,365 | D | $14.47 · — to 2036-03-15 | 23,365 Common Stock | (F5) This option was granted pursuant to the Plan in a transaction exempt under Rule 16b-3 and will vest in four equal annual installments commencing on March 16, 2027. |